Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020

BACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng Province

Saved in:
Bibliographic Details
Main Authors: George,J A, Khoza,S, Mayne,E, Dlamini,S, Kone,N, Jassat,W, Chetty,K, Centner,C M, Pillay,T, Maphayi,M, Mabuza,D, Maposa,I, Cassini,N
Format: Digital revista
Language:English
Published: South African Medical Association 2021
Online Access:http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0256-95742021001100019
record_format ojs
spelling oai:scielo:S0256-957420210011000192021-12-07Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020George,J AKhoza,SMayne,EDlamini,SKone,NJassat,WChetty,KCentner,C MPillay,TMaphayi,MMabuza,DMaposa,ICassini,NBACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng ProvinceSouth African Medical AssociationSAMJ: South African Medical Journal v.111 n.11 20212021-11-01journal articletext/htmlhttp://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019en
institution SCIELO
collection OJS
country Sudáfrica
countrycode ZA
component Revista
access En linea
databasecode rev-scielo-za
tag revista
region África del Sur
libraryname SciELO
language English
format Digital
author George,J A
Khoza,S
Mayne,E
Dlamini,S
Kone,N
Jassat,W
Chetty,K
Centner,C M
Pillay,T
Maphayi,M
Mabuza,D
Maposa,I
Cassini,N
spellingShingle George,J A
Khoza,S
Mayne,E
Dlamini,S
Kone,N
Jassat,W
Chetty,K
Centner,C M
Pillay,T
Maphayi,M
Mabuza,D
Maposa,I
Cassini,N
Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
author_facet George,J A
Khoza,S
Mayne,E
Dlamini,S
Kone,N
Jassat,W
Chetty,K
Centner,C M
Pillay,T
Maphayi,M
Mabuza,D
Maposa,I
Cassini,N
author_sort George,J A
title Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
title_short Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
title_full Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
title_fullStr Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
title_full_unstemmed Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
title_sort sentinel seroprevalence of sars-cov-2 in gauteng province, south africa, august - october 2020
description BACKGROUND: Estimates of prevalence of anti-SARS-CoV-2 antibody positivity (seroprevalence) for tracking the COVID-19 epidemic are lacking for most African countriesOBJECTIVES: To determine the prevalence of antibodies against SARS-CoV-2 in a sentinel cohort of patient samples received for routine testing at tertiary laboratories in Johannesburg, South AfricaMETHODS: This sentinel study was conducted using remnant serum samples received at three National Health Laboratory Service laboratories in the City of Johannesburg (CoJ) district. Collection was from 1 August to 31 October 2020. We extracted accompanying laboratory results for glycated haemoglobin (HbAlc), creatinine, HIV, viral load and CD4 T-cell count. An anti-SARS-CoV-2 targeting the nucleocapsid (N) protein of the Coronavirus with higher affinity for IgM and IgG antibodies was used. We reported crude as well as population-weighted and test-adjusted seroprevalence. Multivariate logistic regression analysis was used to determine whether age, sex, HIV and diabetic status were associated with increased risk for seropositivityRESULTS: A total of 6 477 samples were analysed, the majority (n=5 290) from the CoJ region. After excluding samples with no age or sex stated, the model population-weighted and test-adjusted seroprevalence for the CoJ (n=4 393) was 27.0% (95% confidence interval (CI) 25.4 - 28.6). Seroprevalence was highest in those aged 45 - 49 years (29.8%; 95% CI 25.5 - 35.0) and in those from the most densely populated areas of the CoJ. Risk for seropositivity was highest in those aged 18-49 years (adjusted odds ratio (aOR) 1.52; 95% CI 1.13-2.13; p=0.0005) and in samples from diabetics (aOR 1.36; 95% CI 1.13 - 1.63;p=0.001CONCLUSIONS: Our study conducted between the first and second waves of the pandemic shows high levels of current infection among patients attending public health facilities in Gauteng Province
publisher South African Medical Association
publishDate 2021
url http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742021001100019
work_keys_str_mv AT georgeja sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT khozas sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT maynee sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT dlaminis sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT konen sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT jassatw sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT chettyk sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT centnercm sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT pillayt sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT maphayim sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT mabuzad sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT maposai sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
AT cassinin sentinelseroprevalenceofsarscov2ingautengprovincesouthafricaaugustoctober2020
_version_ 1756005993956769792